NCT00576576View on ClinicalTrials.gov

Evaluation of Atorvastatin on Atherosclerosis Composition

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Atherosclerosis
Interventions
DRUG

Atorvastatin

Atorvastatin 80 mg a day

Trial Locations (1)

30322

Emory University Hospital, Atlanta

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Emory University

OTHER